{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06032949",
            "orgStudyIdInfo": {
                "id": "IRB202301216"
            },
            "organization": {
                "fullName": "University of Florida",
                "class": "OTHER"
            },
            "briefTitle": "Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection",
            "officialTitle": "Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection",
            "therapeuticArea": [
                "Other"
            ],
            "study": "vialize-use-for-the-reduction-of-vascular-groin-incisional-dehiscence-and-infection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-05",
            "studyFirstSubmitQcDate": "2023-09-11",
            "studyFirstPostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Florida",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Groin incisions in vascular surgery have complications in up to 30% of cases at 30 days, resulting in reductions in patient quality of life and increased costs. Prior attempts at reducing this complication rate have been largely unsuccessful. The purpose of this study is to determine the feasibility of routine Vialize use for vascular surgeries involving a groin incision and to determine the rates of surgical site infection/dehiscence in such patients receiving subcutaneous Vialize."
        },
        "conditionsModule": {
            "conditions": [
                "Vascular Diseases"
            ],
            "keywords": [
                "groin infections",
                "quality of life",
                "readmission",
                "groin incisions"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Patients from 2 populations will be included: high-risk patients (any of the following: redo groin incision, active smoker, A1c \\>/= 9.0, BMI \\>/= 30) and non-high-risk patients.",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vialize",
                    "type": "OTHER",
                    "description": "Vialize is a lyophilized dehydrated complete human placental membrane allograft.",
                    "interventionNames": [
                        "Other: Vialize"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Vialize",
                    "description": "Any patients undergoing surgeries involving a groin incision (e.g., femoropopliteal bypass, aortofemoral bypass, loop thigh graft, femoral exposure for delivery of device) will receive Vialize subcutaneously.",
                    "armGroupLabels": [
                        "Vialize"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The rate of infection at 90-day post-op follow-up in patients receiving Vialize during vascular surgeries involving a groin incision.",
                    "description": "Aim 1",
                    "timeFrame": "90-day post-op follow-up"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "The patient quality of life (EQ-5D)",
                    "timeFrame": "90-day post-op follow-up"
                },
                {
                    "measure": "return to OR for groin infection",
                    "timeFrame": "90-day post-op follow-up"
                },
                {
                    "measure": "Readmission or prolongation of the index admission for groin infection",
                    "timeFrame": "90-day post-op follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* The study population will consist of patients undergoing vascular procedures with groin incisions. Patients must be at least 18- years-old and able to complete baseline measurements. All subjects will be compensated. Patients undergoing treatment for peripheral arterial disease (e.g., femoropopliteal bypass), aneurysm disease (e.g., aortofemoral bypass), end-stage kidney disease (e.g., loop thigh graft), and miscellaneous procedures (e.g., femoral exposure for delivery of device) will be eligible.\n\nExclusion Criteria:\n\n* Patients undergoing use of negative pressure wound therapy (e.g., Prevena) and local antibiotic placement (e.g., vancomycin powder) will be excluded. Additionally, organ-transplant recipients will be excluded.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tam Nguyen",
                    "role": "CONTACT",
                    "phone": "352-273-5482",
                    "email": "tam.nguyen@surgery.ufl.edu"
                },
                {
                    "name": "Nancy Hanson",
                    "role": "CONTACT",
                    "phone": "352-273-5479",
                    "email": "nancy.hanson@surgery.ufl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Samir Shah, MD, MPH",
                    "affiliation": "COLLEGE-MEDICINE MD-SURGERY MD-SURGERY-VASCULAR",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UF Health Heart & Vascular Hospital",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32608",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "352-733-8159"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1112",
                    "name": "Surgical Wound",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "asFound": "Vascular Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T6034",
                    "name": "Quality of Life",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        }
    },
    "hasResults": false
}